Bellevue Life Sciences Acquisition Taps Member of Sponsor Team for $60,000

Bellevue Life Sciences Acquisition said it issued an unsecured promissory note for $60,000 to Josh Pan, a member of Bellevue Capital Management, which wholly owns Bellevue Global Life Sciences , the SPAC's sponsor. The note is due by Aug. 8 or when the SPAC closes a deal, whichever is earlier.

The SPAC in November announced a merger agreement with OSR Holdings Co., Ltd., a global healthcare holding company.

Bellevue Life Sciences in July had signed an exclusive, non-binding with OSR. Peter Kuk Hyoun Hwang is CEO of both companies.

The SPAC lost about 38% of its trust to redemptions on an extension vote late last year. The SPAC had raised $69 million in a February .

Bellevue Life Sciences will own at least 60% of the new OSR outstanding shares, with the right to acquire the remainder. 

The merged company would be named OSR Biosciences and its common stock and would list on the Nasdaq Capital Market under new ticker symbols. Read more.


Source: Bellevue Life Sciences Acquisition Taps Member of Sponsor Team for ,000